InvestorsHub Logo
Followers 23
Posts 1907
Boards Moderated 0
Alias Born 12/14/2009

Re: mejs post# 25078

Saturday, 01/05/2013 4:32:43 PM

Saturday, January 05, 2013 4:32:43 PM

Post# of 80490
Quote

ARIA Marketing team will ask two questions, are you prescribing Pona,if not Why Not?

The insurance company will ask, you are prescribing Pona, this drug is not approved for first line treatment? Nor on our preferred drug list? Imagine that? The reason is $


This is where the EPIC trial will come to fruition in the end. IMO Pona will become first line treatment. This does not mean the insurance company’s are willing to pay for the drug, I think they will do everything in their power not to pay.

Keep in mind the insurance companies will revert to Generic, which will soon become available for previous CML drugs.

No , we need to try the drugs that are proven over the years, No we don’t want to see the results of the drug that has healed so many that cost 115,000 a year. That would affect our bottom line.

Thats the bottom line

BoD

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.